Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.

Vegting Y, Reneman L, Booij J.

Psychopharmacology (Berl). 2016 Oct;233(19-20):3473-501. doi: 10.1007/s00213-016-4396-5. Epub 2016 Aug 28. Review.

2.

Brain damages in ketamine addicts as revealed by magnetic resonance imaging.

Wang C, Zheng D, Xu J, Lam W, Yew DT.

Front Neuroanat. 2013 Jul 17;7:23. doi: 10.3389/fnana.2013.00023. eCollection 2013.

3.

Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users.

Bosch OG, Wagner M, Jessen F, Kühn KU, Joe A, Seifritz E, Maier W, Biersack HJ, Quednow BB.

PLoS One. 2013 Apr 9;8(4):e61234. doi: 10.1371/journal.pone.0061234. Print 2013.

4.

Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study.

Moreno-López L, Stamatakis EA, Fernández-Serrano MJ, Gómez-Río M, Rodríguez-Fernández A, Pérez-García M, Verdejo-García A.

PLoS One. 2012;7(6):e39830. doi: 10.1371/journal.pone.0039830. Epub 2012 Jun 29.

5.

MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity.

Salomon RM, Karageorgiou J, Dietrich MS, McLellan JY, Charboneau EJ, Blackford JU, Cowan RL.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):41-7. doi: 10.1016/j.drugalcdep.2011.06.022. Epub 2011 Jul 31.

6.

Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.

Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, Wilkins D, Houle S, Meyer J, Mundo E, Wilson AA, Rusjan PM, Saint-Cyr JA, Guttman M, Collins DL, Shapiro C, Warsh JJ, Boileau I.

Brain. 2010 Jun;133(Pt 6):1779-97. doi: 10.1093/brain/awq103. Epub 2010 May 17.

7.

Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.

Licata SC, Renshaw PF.

Ann N Y Acad Sci. 2010 Feb;1187:148-71. doi: 10.1111/j.1749-6632.2009.05143.x. Review.

8.

Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.

Gouzoulis-Mayfrank E, Daumann J.

Dialogues Clin Neurosci. 2009;11(3):305-17. Review.

9.

Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.

Karageorgiou J, Dietrich MS, Charboneau EJ, Woodward ND, Blackford JU, Salomon RM, Cowan RL.

Neuroimage. 2009 Jul 1;46(3):817-26. doi: 10.1016/j.neuroimage.2009.02.029. Epub 2009 Mar 2.

10.

Supplemental Content

Support Center